Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Robustness of the ferret model for influenza risk assessment studies: a cross-laboratory exercise
Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
